IRD · Forms 3, 4, 5
Insider trades at Opus Genetics, Inc.
1 insider sold $2.8M of Opus Genetics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Opus Genetics, Inc. (IRD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 556,000 | $4.96 | $2.8M | Form 4 | |
| George Magrath | Chief Executive Officer | Option exercise | 392,157 | $1.15 | $451K | Form 4 | |
| George Magrath | Chief Executive Officer | Tax withholding | 75,541 | $5.97 | $451K | Form 4 | |
| Cam Gallagher | Director | Option exercise | 784,314 | $1.15 | $902K | Form 4 | |
| Robert E. Gagnon | Chief Financial Officer | Sell | 28,000 | $4.54 | $127K | Form 4 | |
| Benjamin R Yerxa | President | Sell | 7,429 | $2.97 | $22K | Form 4 | |
| Joseph K Schachle | Chief Operating Officer | Sell | 4,644 | $2.94 | $14K | Form 4 | |
| George Magrath | Chief Executive Officer | Sell | 9,475 | $2.95 | $28K | Form 4 | |
| Robert E. Gagnon | Chief Financial Officer | Sell | 7,783 | $2.95 | $23K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.